Serum HCV RNA levels assessed by quantitative NASBA®: Stability of viral load over time, and lack of correlation with liver disease

Journal of Hepatology

Volumn 25, Issue 3, 1996, Pages 301-306

  Hollingsworth, Rosalind C ^a,b   Sillekens, Peter ^b   Van Deursen, Peter ^b   Neal, Keith R ^a   Irving, William L ^a   James, V ^c   Jones, D A ^c   Hollingsworth, R ^c   Irving, W ^c   Neal, K ^c   Bennett, D ^c   Eglin, R P ^c   Finch, R G ^c   Underwood, J C E ^c   McKendrick, M ^c   Gleeson, D ^c   Scott, B B ^c   Nicholson, K G ^c   Wiselka, M ^c   Freeman, J ^c  

^a Organon Teknika   (Netherlands)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c NONE

Author keywords

Chronic hepatitis; Hepatitis C virus; NASBA ; RNA quantitation

Indexed keywords

ADULT; ARTICLE; BLOOD ANALYSIS; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ASSAY; TECHNIQUE; VIRUS CONCENTRATION;

EID: 0030249544     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80115-2     Document Type: Article

References (23)

1. Gunji T, Kato N, Mori S, Ootsuyama Y, Hijikata M, Imawari M, Shimotohmo K. Correlation between the serum level of hepatitis C virus RNA and disease activities in acute and chronic hepatitis C. Int J Cancer. 52:1992;726-730.
2. Shindo M, Di Bisceglie AM, Cheung L, Shih J.W., Cristiano K, Feinstone SM, Hoofnagle JH. Decrease of serum hepatitis C viral RNA during alpha interferon treatment for chronic hepatitis C. Ann Intern Med. 115:1991;700-704.
3. Hagiwara H, Hayashi N, Mita E, Naito M, Kasahara A, Fusamoto H, Kamada T. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology. 17:1993;545-550.
4. Hagiwara H, Hayashi N, Mita E, Takehara T, Kasahara A, Fusamoto H, Kamada T. Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy. Gastroenterology. 104:1993;877-883.
5. Naito M, Hayashi N, Hagiwara H, Katayama K, Kasahara A, Fusamoto H, Kato M, Masuzawa M, Kamada T. Serial quantitative analysis of serum hepatitis C virus RNA level in patients with acute and chronic hepatitis C. J Hepatol. 20:1994;755-759.
6. Lau JYN, Davis GL, Kniffen J, Qian K.-P., Urdea MS, Chan C.S., Mizokami M, Nenwald PD, Wilber JC. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 341:1993;1501-1504.
7. Van Gemen B, van Beuningen R, Nabbe A, van Strijp D, Jurriaans, Lens P, Kievits T. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes. J Virol Methods. 49:1994;157-168.
8. Kievits T, van Gemen B, van Strijp D, Schukkink R, Dircks M, Adriaanse H, Malek L, Sooknanan, Lens P. NASBA isothermal enzymatic in vitro amplification optimized for the diagnosis of HIV-1 infection. J Virol Methods. 35:1991;273-286.
9. ™ as a diagnostic tool. Hepatitis C Virus. GEMHEP. 1994;71-82 John Libbey Eurotext, Paris.
10. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
11. Makris M, Preston FE, Triger DR, Underwood JCE, Westlake L, Adelman MI. Randomised controlled trial of recombinant interferon-alpha in chronic hepatitis C in haemophiliacs. Blood. 78:1991;1672-1677.
12. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-van Dillen PME, Noordaa van der J. A rapid and simple method for purification of nucleic acids. J Clin Microbiol. 28:1990;495-503.
13. Bukh J, Purcell RH, Miller RH. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc Natl Acad Sci USA. 89:1992;4942-4946.
14. Simmonds P, Rose KA, Graham S, Chan S.-W., McOrnish F, Dow BC, Follett EAC, Yap PL, Marsden H. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol. 31:1993;1493-1503.
15. Yamada M, Kakomu S, Yoshioka K, Higashi Y, Tanaka K, Ishikawa T, Takayanagi M. Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci. 39:1994;234-239.
16. Naito M, Hayashi N, Hagiwara H, Hiramatsu N, Kasahara A, Fusamoto H, Kamada T. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology. 19:1994;871-875.
17. Gretch D, Corey L, Wilson J, dela Rosa C, Wilson R, Carithers R Jr, Busch M, Hart J, Sayers M, Han J. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high titer viremia correlates with advanced stage of disease. J Infect Dis. 169:1994;1219-1225.
18. Sakamoto N, Enomoto N, Kurosaki M, Marumo F, Sato C. Detection and quantification of hepatitis C virus RNA replication in the liver. J Hepatol. 20:1994;593-597.
19. Garson JA, Tuke PW, Makris M, Briggs M, Machin JJ, Preston PE, Tedder RS. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis C virus contaminated factor VIII concentrates. Lancet. 336:1990;1022-15.
20. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller 1K, Gerber MA, Sampliner RE, Meeks EL. Beach MJ for the Sentinel Counties Chronic Non-A, Non-B Hepatitis Study Team. The natural history of community-acquired hepatitis C in the United States. N Engl J Med. 327:1992;1899-1905.
21. Wang JT, Sheu JC, Lin JT, Wang TH, Chen DS. Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells. J Infect Dis. 166:1992;1167-1169.
22. Zignego AL, Macchia D, Monti M, Thiers V, Mazetti M, Foschi M, Maggi E, Romagnani S, Gentilini P, Brechot C. Infection of peripheral blood mononuclear cells by hepatitis C virus. J Hepatol. 15:1992;382-386.
23. Müller HM, Kallinowski B, Solbach C, Theilmann L, Goeser T, Pfaff E. B-lymphocytes are predominantly involved in viral propagation of hepatitis C virus (HCV). Arch Virol (Suppl). 9:1994;307-316.